Drug intelligence / Profile preview

N-Shine NT

Development stage
Unknown
Lead developer
Healthon Life Sciences
Modality
Small Molecules
Administration
Oral
01

Overview

N-Shine NT is a fixed-dose combination tablet manufactured by Healthon Lifesciences, primarily used for the treatment of neuropathic pain. It integrates three active components: Pregabalin (75mg), Nortriptyline (10mg), and Methylcobalamin (1500mcg). Pregabalin acts as an alpha-2-delta ligand, binding to voltage-gated calcium channels in the central nervous system to reduce the release of excitatory neurotransmitters. Nortriptyline is a tricyclic antidepressant that inhibits the reuptake of norepinephrine and, to a lesser extent, serotonin, thereby enhancing descending inhibitory pain pathways. Methylcobalamin, a form of Vitamin B12, serves as a cofactor in the synthesis of methionine and supports the regeneration of the myelin sheath, promoting nerve repair. This triple-action formulation addresses pain signaling, mood regulation, and structural nerve health.

Brand names
N-Shine NT
Other names
Pregabalin + Nortriptyline + Methylcobalamin
02

Targets

α2δ (Voltage-gated calcium channel alpha-2-delta subunit)SERT (Sodium-dependent serotonin transporter)NET (Norepinephrine Transporter)MTR (Methionine synthase)

Beyond the preview

Go deeper on N-Shine NT.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on N-Shine NT.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call